KUALA LUMPUR: TPG Capital Asia has completed its acquisition of Gribbles Pathology (M) Sdn Bhd, a leading pathology lab in Malaysia.
According to TPG Capital, the Asian investment platform of global alternative asset firm TPG, the acquisition forms part of its A$279mil (RM831.9mil) purchase of Healthscope Ltd’s Asian pathology laboratories in Malaysia, Singapore, and Vietnam.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!